No actionable trading signal from this routine proxy notice. Monitor for any dissident shareholder activity or material changes in the definitive proxy statement ahead of the June 17 meeting.
Price Chart
Executive Summary
Acrivon Therapeutics filed a DEFA14A (definitive additional proxy soliciting materials) for its upcoming Annual Meeting of Stockholders on June 17, 2026. The board recommends voting FOR the election of Class I directors Michael Tomsicek and Charles Baum, and FOR the ratification of PricewaterhouseCoopers as independent auditor for FY2026. This is a routine proxy notice with no material financial disclosures or activist involvement.
Key Financial Metrics
Key Facts
- Annual Meeting of Stockholders scheduled for June 17, 2026 at 1:00 PM ET, held virtually
- Stockholders of record as of April 23, 2026 are entitled to vote
- Board recommends FOR all director nominees (Michael Tomsicek and Charles Baum) and FOR ratification of PricewaterhouseCoopers as auditor
- Paper proxy material request deadline is June 5, 2026
- Filing is a routine definitive additional proxy soliciting material (DEFA14A)
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No material risks identified from this routine filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-194211 |
| Document: 0001193125-26-194211-index-headers.html | 0001193125-26-194211 |
| Document: 0001193125-26-194211-index.html | 0001193125-26-194211 |
| Document: 0001193125-26-194211.txt | 0001193125-26-194211 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 21, 2026 13w ago | Press Release | $1.68 $1.76 | ▲ +4.76% | ▲ +1.50% | $1.73 (+2.98%) |
May 22, 2026 22w ago | DEFA14A | $1.67 $2.39 | ▲ +43.11% | ▲ +40.39% | $1.73 (+3.59%) |
Apr 30, 2026 25w ago | DEFA14A | $1.85 $1.56 | ▼ −15.68% | ▼ −18.78% | $1.73 (−6.49%) |
Mar 19, 2026 31w ago | Press Release | $1.70 $1.52 | ▼ −10.59% | ▼ −24.93% | $1.73 (+1.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers